Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).

Suppr

超能文献

作者信息

Breckenridge A, Orme M L, Thorgeirsson S, Davies D S, Brooks R V

出版信息

Clin Sci. 1971 Apr;40(4):351-64. doi: 10.1042/cs0400351.

DOI:10.1042/cs0400351

PMID:5575281

Abstract

摘要

相似文献

Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).

Clin Sci. 1971 Apr;40(4):351-64. doi: 10.1042/cs0400351.

Induction of drug metabolizing enzymes in man and rat by dichloralphenazone.

Clin Sci. 1969 Oct;37(2):565.

Induction of drug metabolizing enzymes in man.

Clin Sci. 1970 Sep;39(3):11P. doi: 10.1042/cs039011pa.

Oral anticoagulants--the totem and the taboo.

Br Med J. 1976 Feb 21;1(6007):419-23. doi: 10.1136/bmj.1.6007.419.

Interaction between phenytoin and dichloralphenazone [proceedings].

Br J Clin Pharmacol. 1980 Jan;9(1):118P. doi: 10.1111/j.1365-2125.1980.tb04820.x.

Clinical implications of enzyme induction.

Ann N Y Acad Sci. 1971 Jul 6;179:421-31. doi: 10.1111/j.1749-6632.1971.tb46919.x.

The effect of dichloralphenazone pretreatment on paracetamol hepatotoxicity in mice.

Biochem Pharmacol. 1979 Oct 1;28(19):3035-7. doi: 10.1016/0006-2952(79)90609-9.

Dose-dependent enzyme induction.

Clin Pharmacol Ther. 1973 Jul-Aug;14(4):514-20. doi: 10.1002/cpt1973144part1514.

Pathophysiological factors influencing drug kinetics.

Acta Pharmacol Toxicol (Copenh). 1971;29 Suppl 3:225-32. doi: 10.1111/j.1600-0773.1971.tb03302.x.

Sleep and hypnotics: further experiments.

Br Med J. 1970 Aug 8;3(5718):310-3. doi: 10.1136/bmj.3.5718.310.

引用本文的文献

Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.

Br J Clin Pharmacol. 1974 Jun;1(3):253-7. doi: 10.1111/j.1365-2125.1974.tb00246.x.

Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Eur J Clin Pharmacol. 2003 Dec;59(10):713-33. doi: 10.1007/s00228-003-0690-3. Epub 2003 Nov 6.

The effect of fever on antipyrine metabolism in children.

Br J Clin Pharmacol. 1982 Jun;13(6):811-5. doi: 10.1111/j.1365-2125.1982.tb01871.x.

Differential effects of enzyme induction on antipyrine metabolite formation.

Br J Clin Pharmacol. 1982 Mar;13(3):379-86. doi: 10.1111/j.1365-2125.1982.tb01389.x.

Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man.

Eur J Clin Pharmacol. 1983;24(2):247-50. doi: 10.1007/BF00613826.

The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.

Klin Wochenschr. 1983 Sep 1;61(17):851-8. doi: 10.1007/BF01537460.

Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.

Br J Clin Pharmacol. 1982 Dec;14(6):861-5. doi: 10.1111/j.1365-2125.1982.tb02050.x.

Assessment of the drug metabolism capacity of the liver.

Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x.

Clinical implications of enzyme induction and enzyme inhibition.

Clin Pharmacokinet. 1981 Jan-Feb;6(1):1-24. doi: 10.2165/00003088-198106010-00001.

Anticoagulant interactions.

Br Med J. 1971 Nov 27;4(5786):560. doi: 10.1136/bmj.4.5786.560-d.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).

Clin Sci. 1971 Apr;40(4):351-64. doi: 10.1042/cs0400351.

Induction of drug metabolizing enzymes in man and rat by dichloralphenazone.

Clin Sci. 1969 Oct;37(2):565.

Induction of drug metabolizing enzymes in man.

Clin Sci. 1970 Sep;39(3):11P. doi: 10.1042/cs039011pa.

Oral anticoagulants--the totem and the taboo.

Br Med J. 1976 Feb 21;1(6007):419-23. doi: 10.1136/bmj.1.6007.419.

Interaction between phenytoin and dichloralphenazone [proceedings].

Br J Clin Pharmacol. 1980 Jan;9(1):118P. doi: 10.1111/j.1365-2125.1980.tb04820.x.

Clinical implications of enzyme induction.

Ann N Y Acad Sci. 1971 Jul 6;179:421-31. doi: 10.1111/j.1749-6632.1971.tb46919.x.

The effect of dichloralphenazone pretreatment on paracetamol hepatotoxicity in mice.

Biochem Pharmacol. 1979 Oct 1;28(19):3035-7. doi: 10.1016/0006-2952(79)90609-9.

Dose-dependent enzyme induction.

Clin Pharmacol Ther. 1973 Jul-Aug;14(4):514-20. doi: 10.1002/cpt1973144part1514.

Pathophysiological factors influencing drug kinetics.

Acta Pharmacol Toxicol (Copenh). 1971;29 Suppl 3:225-32. doi: 10.1111/j.1600-0773.1971.tb03302.x.

Sleep and hypnotics: further experiments.

Br Med J. 1970 Aug 8;3(5718):310-3. doi: 10.1136/bmj.3.5718.310.

引用本文的文献

Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.

Br J Clin Pharmacol. 1974 Jun;1(3):253-7. doi: 10.1111/j.1365-2125.1974.tb00246.x.

Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Eur J Clin Pharmacol. 2003 Dec;59(10):713-33. doi: 10.1007/s00228-003-0690-3. Epub 2003 Nov 6.

The effect of fever on antipyrine metabolism in children.

Br J Clin Pharmacol. 1982 Jun;13(6):811-5. doi: 10.1111/j.1365-2125.1982.tb01871.x.

Differential effects of enzyme induction on antipyrine metabolite formation.

Br J Clin Pharmacol. 1982 Mar;13(3):379-86. doi: 10.1111/j.1365-2125.1982.tb01389.x.

Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man.

Eur J Clin Pharmacol. 1983;24(2):247-50. doi: 10.1007/BF00613826.

The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.

Klin Wochenschr. 1983 Sep 1;61(17):851-8. doi: 10.1007/BF01537460.

Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.

Br J Clin Pharmacol. 1982 Dec;14(6):861-5. doi: 10.1111/j.1365-2125.1982.tb02050.x.

Assessment of the drug metabolism capacity of the liver.

Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x.

Clinical implications of enzyme induction and enzyme inhibition.

Clin Pharmacokinet. 1981 Jan-Feb;6(1):1-24. doi: 10.2165/00003088-198106010-00001.

Anticoagulant interactions.

Br Med J. 1971 Nov 27;4(5786):560. doi: 10.1136/bmj.4.5786.560-d.